Esperion grants 260,000 RSUs to 23 new employees under inducement plan

Esperion Therapeutics, Inc.

Esperion Therapeutics, Inc.

ESPR

0.00
  • Esperion Therapeutics granted 260,000 restricted stock units to 23 new employees on May 12, 2026, under its 2017 Inducement Equity Incentive Plan.
  • RSUs vest 25% on one-year anniversary of vesting commencement date, with remaining 75% vesting in 12 equal quarterly installments, subject to continued employment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esperion Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605141630PRIMZONEFULLFEED9720484) on May 14, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.